Tyche Wealth Partners LLC Makes New $302,000 Investment in The Clorox Company (NYSE:CLX)

Tyche Wealth Partners LLC acquired a new position in shares of The Clorox Company (NYSE:CLX) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,117 shares of the company’s stock, valued at approximately $302,000.

Several other large investors have also recently added to or reduced their stakes in CLX. Norges Bank bought a new stake in Clorox during the fourth quarter worth about $101,609,000. Imprint Wealth LLC grew its stake in Clorox by 16,986.8% during the second quarter. Imprint Wealth LLC now owns 551,392 shares of the company’s stock worth $55,139,000 after buying an additional 548,165 shares during the last quarter. Qube Research & Technologies Ltd grew its stake in Clorox by 75.9% during the third quarter. Qube Research & Technologies Ltd now owns 1,130,481 shares of the company’s stock worth $148,161,000 after buying an additional 487,974 shares during the last quarter. International Assets Investment Management LLC grew its stake in Clorox by 17,658.5% during the fourth quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after buying an additional 481,725 shares during the last quarter. Finally, Acadian Asset Management LLC lifted its position in shares of Clorox by 39.6% during the third quarter. Acadian Asset Management LLC now owns 1,467,713 shares of the company’s stock worth $192,319,000 after purchasing an additional 415,999 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Trading Down 0.1 %

Shares of NYSE CLX opened at $142.29 on Thursday. The company’s 50 day simple moving average is $150.40 and its 200 day simple moving average is $141.69. The company has a debt-to-equity ratio of 11.37, a current ratio of 0.89 and a quick ratio of 0.57. The firm has a market capitalization of $17.66 billion, a P/E ratio of 225.86, a P/E/G ratio of 2.22 and a beta of 0.43. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $178.21.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, topping the consensus estimate of $1.08 by $1.08. The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.80 billion. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The business’s revenue for the quarter was up 16.0% compared to the same quarter last year. During the same period last year, the business posted $0.98 earnings per share. On average, analysts predict that The Clorox Company will post 5.52 EPS for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be issued a $1.20 dividend. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 annualized dividend and a yield of 3.37%. Clorox’s dividend payout ratio (DPR) is presently 761.92%.

Analyst Upgrades and Downgrades

CLX has been the topic of a number of research reports. The Goldman Sachs Group initiated coverage on shares of Clorox in a research report on Friday, March 1st. They set a “sell” rating and a $140.00 target price on the stock. Barclays reduced their target price on shares of Clorox from $148.00 to $136.00 and set an “underweight” rating on the stock in a research report on Wednesday, April 10th. JPMorgan Chase & Co. upped their target price on shares of Clorox from $145.00 to $152.00 and gave the stock a “neutral” rating in a research report on Thursday, January 18th. UBS Group upped their target price on shares of Clorox from $145.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, February 2nd. Finally, Jefferies Financial Group upgraded shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 target price on the stock in a research report on Tuesday, March 26th. Four research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $148.63.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.